Viewing Study NCT03257033


Ignite Creation Date: 2025-12-25 @ 2:54 AM
Ignite Modification Date: 2026-05-22 @ 1:42 PM
Study NCT ID: NCT03257033
Status: RECRUITING
Last Update Posted: 2025-11-14
First Post: 2017-08-17
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPC
Sponsor: RenovoRx
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Locally Advanced Pancreatic Cancer View
Keywords: